Maze Therapeutics
Precision Medicine · Rare Disease Therapeutics
12open roles
$269kmedian advertised pay
Btruth index, 75 of 100
23stories in the press
Overview
Maze Therapeutics is a biopharmaceutical company that uses human genetics to discover and develop treatments for patients with rare and common diseases. It hires clinical operations, data management, chemical development and information technology leaders. The company is headquartered in South San Francisco, United States.
How Maze Therapeutics hires
Truth index
B 75/100
Ghost roles
0%
Stale roles
100%
Reposted roles
0%
Maze Therapeutics scores B on the Alion truth index (A is best, E worst), measured over 6 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
Jobs
$219k – $267k per year · Equity · Hybrid · 10+ years exp · Bachelor's Degree · South San Francisco
GMP
ICH Guidelines
MedTech
21 CFR Part 11
CAPA
Apply
$125k – $152k per year · Equity · Hybrid · 2+ years exp · Bachelor's Degree · South San Francisco
GCP
Life Sciences
Veeva
Medidata Rave
Apply
$176k – $215k per year · Equity · In office · 5+ years exp · Bachelor's Degree · South San Francisco
Good Clinical Practice
Veeva
Medidata Rave
Apply
$143k – $175k per year · Equity · Hybrid · 4+ years exp · South San Francisco
GCP
Life Sciences
Good Clinical Practice
Veeva
Medidata Rave
Apply
$205k – $295k per year · Equity · Remote (United States) · 7+ years exp · PhD · South San Francisco
Apply
$205k – $295k per year · Equity · Remote (United States) · 7+ years exp · PhD · South San Francisco
Apply
$205k – $295k per year · Equity · Remote (United States) · 7+ years exp · PhD · South San Francisco
Apply
$270k – $330k per year · Equity · Hybrid · 15+ years exp · South San Francisco
GDPR
Management
SharePoint
Apply
$158k – $193k per year · Equity · Hybrid · PhD · South San Francisco
GMP
Apply
$181k – $221k per year · Equity · Hybrid · 8+ years exp · Bachelor's Degree · South San Francisco
GCP
Management
Smartsheet
Microsoft Project
Apply
$223k – $271k per year · Equity · Hybrid · Bachelor's Degree · South San Francisco
Apply
$232k – $284k per year · Equity · Hybrid · 8+ years exp · Bachelor's Degree · South San Francisco
Oracle
Life Sciences
Medidata Rave
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$269k
Typical range
$128k – $330k
Open positions
14
13
Jobs
Middle
15.4%
Senior
30.8%
Architect
53.8%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 2 | $152k | $128k – $175k |
| Senior | 4 | $218k | $152k – $330k |
| Architect | 7 | $284k | $267k – $295k |
Highest paying role
Senior Director, Information Technology
$330k
Normalized to USD per year
All salaries at Maze Therapeutics
By role, level and city, against the market · 14 jobs with pay
Visa sponsorship
4 ▲ 33%
H-1B filings in 12 months
1
Green card filings
$128k
Median offered salary
Who they sponsor
Other biological scientists
3
Other managers
1
In the register as Maze Therapeutics Inc., South San Francisco, CA (+1 more)
Other sponsors in the same field
Bridgebio 
ProFound Therapeutics 
Mirador Therapeutics 
Genentech
See 14 open roles Alert me
US Department of Labor · latest filing Jun 22, 2026 · Visa details by country
Growth
Hiring Momentum
45/100
Stable
Open positions
14
2 opened / 1 closed in 30 days
Median time-to-fill
67 days
faster than 18% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
63% ▼
Leadership
13% ▼
Administrative
13% ▲
Industrial Engineering
13% ▲
Activity Timeline
New location: United States
Nov 2026
Added ICH Guidelines to stack
Oct 2026
Added 21 CFR Part 11 to stack
Oct 2026
Added CAPA to stack
Oct 2026
Added Good Clinical Practice to stack
Oct 2026
Added Veeva to stack
Oct 2026
Added Outlook to stack
Oct 2026
Added GMP to stack
Oct 2026
Added Medidata Rave to stack
Oct 2026
Tech stack
Technologies named in job postings at Maze Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
9
Postings analysed
10
Stack modernity
57/100
Databases
Oracle10%
Cloud & platforms
GCP40%
Sign in to see how your skills match this stack
Sign In
Full Maze Therapeutics tech stack
9 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
ARCH Venture PartnersVia a fund
GVVia a fund
569 portfolio companies
General CatalystVia a fund
610 portfolio companies
Andreessen HorowitzVia a fund
857 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000
Motley Fool Press Release.
Read more
Report
Maze Therapeutics Announces Appointments to Its Board of Directors
August 13, 2026 PDF Version Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., join Maze's Board of Directors, adding to the Company's deep bench of clinical and industry experience SOUTH SAN FRANCISCO, Calif., Aug. 13, 2026 (GLOBE NEWSW
Read more
Report
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
August 11, 2026 PDF Version Enrollment in Phase 2 HORIZON trial of MZE829 on track; data from all cohorts expected in late 2026 or early 2027 Phase 2 CIPheR trial of MZE782 in PKU initiated and enrollment ongoing; topline data expected in 2027 Phase 2 tri
Read more
Report
APRIL 2026 MAZE THERAPEUTICS
Expanding the Universe of SLC6A19 Substrates: SLC Inhibition Protects Kidney from Nephrotoxic Metabolite Accumulation The post APRIL 2026 MAZE THERAPEUTICS appeared first on Maze Therapeutics.
Read more
Report
MARCH 2026 MAZE THERAPEUTICS and Certara, Inc.
Translating PD changes from healthy volunteers to Phenylketonuria patients for MZE782 treatment using a mechanistic PK PD model The post MARCH 2026 MAZE THERAPEUTICS and Certara, Inc. appeared first on Maze Therapeutics.
Read more
Report
Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.
This clinical-stage biotech focused on precision medicines for kidney and metabolic diseases just reported a notable insider sale.
Read more
Report
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
May 27, 2026 PPDF Version SOUTH SAN FRANCISCO, Calif., May 27, 2026 (GLOBE NEWSWIRE) - Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic
Read more
Report
Maze Therapeutics posts trial data for lead drug (MAZE:NASDAQ)
Maze Therapeutics (MAZE) stock plunged even as the company posts positive Phase 2 trial data for lead asset MZE829 in APOL1-mediated kidney disease. Read more here.
Read more
Report
Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock
Maze Therapeutics' Senior Vice President of Finance sold shares towards the end of January 2026, all while the company's stock had one of the best first-year performances of a biopharmaceutical company.
Read more
Report
Maze Therapeutics: An Innovative, Nature-Driven Platform (NASDAQ:MAZE)
Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in 2026. Learn why MAZE stock is a strong buy.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
South San Francisco
South San Francisco
United States
HQ
14 open roles 10 posted in 90 days 21% remote $242k Avg Salary
hires for Biotech, Leadership, Administrative
171 Oyster Point Blvd, Suite 300, South San Francisco, CA 94080